Hermetica Superfood Encyclopedia
The Short Answer
Puri Puri leaves contain flavonoids (including quercetin-type compounds), phenolic acids, tannins, anthocyanins, and volatile terpenoids such as spathulenol and germacrene-D that exert antioxidant, anti-inflammatory, and antimicrobial effects through NF-κB pathway inhibition, free-radical scavenging, and bacterial membrane disruption. Preclinical evidence documents DPPH radical scavenging with an IC₅₀ of 70.06–244.42 µg/mL and antibacterial activity against pathogens including Klebsiella pneumoniae and Streptococcus pyogenes, supporting its traditional topical and internal wound-healing applications in Papua New Guinea.
CategoryHerb
GroupPacific Islands
Evidence LevelPreliminary
Primary KeywordPuri Puri benefits
Puri Puri — botanical close-up
Health Benefits
**Wound Healing Support**
Traditionally applied to wounds in the Siwai and Buin regions of PNG; phenolic compounds and tannins are thought to promote tissue repair by reducing oxidative burden and limiting microbial colonisation at wound sites.
**Antioxidant Activity**: Total flavonoid content reaching 8
59 mg RE/g in 96% ethanol leaf extracts scavenges DPPH and nitric oxide radicals (IC₅₀ 70.06–244.42 µg/mL and 2.52×10³ µg/mL respectively), reducing oxidative stress at the cellular level.
**Anti-Inflammatory Effects**
Flavonoids and phenolic acids inhibit the NF-κB signalling pathway, thereby reducing downstream production of pro-inflammatory cytokines, reactive nitrogen species, and leukocyte migration into inflamed tissues.
**Antimicrobial Properties**
Quercetin-type flavonoids and volatile constituents including thymol, carvacrol, and eugenol disrupt bacterial cell membranes and inhibit nucleic acid synthesis, showing activity against Klebsiella pneumoniae, Salmonella typhi, Streptococcus agalactiae, and Streptococcus pyogenes.
**Immunostimulant Activity**
Oral administration of Miana (Coleus scutellarioides) leaf extract in animal models of Klebsiella infection upregulated NRAMP-1 gene expression, enhancing macrophage activation and intracellular pathogen clearance.
**Antipyretic Potential**
Traditional use across Indonesia and the Pacific includes fever reduction; the anti-inflammatory cascade mediated by NF-κB suppression and reduced nitric oxide production provides a plausible mechanistic basis for this effect.
**Metabolic Enzyme Inhibition**
Ethanolic leaf extracts demonstrate moderate inhibition of α-glucosidase (IC₅₀ 630 µg/mL) and weak inhibition of xanthine oxidase (IC₅₀ 900 µg/mL), suggesting modest potential relevance to post-prandial glucose management and gout-related oxidative stress, though human evidence is absent.
Origin & History
Natural habitat
Coleus scutellarioides is native to tropical Southeast Asia, with its range extending across Indonesia, the Philippines, and into the Pacific Islands including Papua New Guinea, where it is used in the Siwai and Buin areas of Bougainville. The plant thrives in humid, tropical lowland and montane environments, tolerating partial shade and moist, well-drained soils, and is widely cultivated as an ornamental as well as a medicinal herb. In Indonesia it is commonly known as Miana, and traditional cultivation involves propagation from stem cuttings, with the aromatic leaves harvested throughout the year for fresh or dried preparation.
“Coleus scutellarioides has been integrated into the traditional medicine of numerous Pacific and Southeast Asian communities for centuries, most notably in Indonesia where it is called Miana and used to treat infections, fever, inflammation, and wounds, and in Papua New Guinea's Siwai and Buin areas of Bougainville where it carries the name Puri Puri and is specifically applied to wound management. In Indonesian ethnomedicine, Miana leaves are prepared as oral decoctions for immunostimulation and antipyretic purposes, with recorded use against respiratory and gastrointestinal infections predating formal pharmacological study. The plant also holds ornamental and cultural significance across much of tropical Asia and the Pacific, where its richly pigmented leaves associate it with protective and healing symbolism in various indigenous knowledge systems. Formal documentation of its PNG wound-healing use has appeared in ethnobotanical surveys of medicinal plant use in Bougainville, situating it within a broader tradition of tropical leaf medicine used by communities with limited access to biomedical facilities.”Traditional Medicine
Scientific Research
Available evidence for Coleus scutellarioides is limited to in vitro phytochemical and bioactivity assays and a small number of animal studies, with no peer-reviewed human clinical trials reporting sample sizes, effect sizes, or controlled outcomes. In vitro studies have quantified antioxidant capacity (DPPH IC₅₀ 70.06–244.42 µg/mL), antibacterial minimum inhibitory concentrations against several gram-positive and gram-negative pathogens, and enzyme inhibition parameters for α-glucosidase and xanthine oxidase using crude and concentrated ethanolic extracts. Animal-model evidence includes oral administration studies in Klebsiella pneumoniae-infected rodents demonstrating increased NRAMP-1 gene expression, supporting immunostimulant claims but providing no translatable human dose-response data. The traditional wound-healing use in PNG's Siwai and Buin communities constitutes ethnobotanical validation rather than clinical proof, and the overall evidence base must be characterised as preliminary.
Preparation & Dosage
Traditional preparation
**Traditional Decoction (PNG/Indonesia)**
Fresh or dried leaves boiled in water and applied topically to wounds or consumed as a liquid preparation; no standardised volume or concentration established.
**Ethanolic Extract (Research Standard)**
3 g of dried leaves macerated in 95–96% ethanol, filtered, and concentrated; concentrations tested in vitro range from 70–10,000 µg/mL
Approximately .
**Water Extract**
Aqueous extracts prepared by decoction and concentrated using a rotary evaporator or freeze dryer; water-soluble phenolics and flavonoids predominate in this fraction.
**Freeze-Dried Powder**
No commercially standardised supplement form exists; researchers have used freeze-dried crude extracts without defined standardisation percentages.
**Dose (Human)**
No clinically validated human dose has been established; traditional use does not specify precise quantities, and no dose-ranging studies have been published.
**Timing**
Traditional preparations are applied fresh to wounds as needed or consumed as infusions; no pharmacokinetic data inform optimal timing.
Nutritional Profile
Coleus scutellarioides leaves contain a diverse phytochemical matrix rather than a nutritionally significant macronutrient or micronutrient profile. Total flavonoid content is quantified at 0.59 mg quercetin equivalents (QE)/g in crude dried material rising to 1.64 mg QE/g in concentrated extract, and 8.59 mg rutin equivalents (RE)/g in 96% ethanol leaf extract. Phenolic acids, tannins, saponins, and alkaloids are confirmed by standard phytochemical screening. Volatile essential oil fractions include spathulenol (24.57%), germacrene-D (14.53%), thymol, carvacrol, and eugenol, with total volatiles reaching up to 10,579 µg/g dry weight under naphthalene acetic acid (NAA) supplementation in vitro cultures. Anthocyanins contribute to the plant's characteristic red-purple pigmentation and possess antioxidant properties; precise anthocyanin concentrations in field-grown material have not been uniformly reported. Bioavailability data for any constituent in humans is absent from the published literature.
How It Works
Mechanism of Action
The primary antioxidant mechanism involves flavonoids and phenolic acids donating hydrogen atoms to neutralise DPPH and nitric oxide radicals, with quercetin-type compounds chelating transition metals that would otherwise catalyse hydroxyl radical formation. Anti-inflammatory activity proceeds through inhibition of the NF-κB transcription factor pathway, reducing expression of pro-inflammatory mediators, reactive nitrogen species, and adhesion molecules that drive leukocyte recruitment, while simultaneously modulating Toll-like receptor (TLR) signalling and downregulating HMGB-1 gene expression. Antimicrobial effects are attributed to flavonoid complexation with extracellular bacterial proteins, direct disruption of phospholipid bilayer integrity by thymol and carvacrol volatiles, and quercetin-mediated inhibition of bacterial DNA gyrase and topoisomerase IV, collectively impairing nucleic acid synthesis and membrane permeability. Immunostimulation is mechanistically linked to upregulation of NRAMP-1 (Natural Resistance-Associated Macrophage Protein 1), which enhances divalent cation sequestration within phagolysosomes, restricting intracellular bacterial survival.
Clinical Evidence
No human clinical trials have been conducted or published for Puri Puri (Coleus scutellarioides) in any therapeutic indication, including wound healing, infection, inflammation, or metabolic disease. The totality of formalised research consists of in vitro bioassays conducted at concentrations ranging from 70 to 10,000 µg/mL and animal immunostimulation experiments, neither of which can be directly extrapolated to human efficacy or safe dosing. Effect sizes, confidence intervals, and clinically meaningful endpoints remain entirely unestablished in human populations. Confidence in the therapeutic claims is therefore low from an evidence-based medicine standpoint, and use is presently justified only within the context of traditional ethnomedical practice pending properly designed clinical investigation.
Safety & Interactions
Formal safety pharmacology studies, toxicological assessments, and human adverse event data for Coleus scutellarioides are not available in the peer-reviewed literature, making it impossible to define a maximum safe dose, NOAEL, or evidence-based contraindication profile with confidence. Traditional use across Indonesia and Papua New Guinea spanning decades without reported systematic adverse effects provides limited reassurance of general tolerability at typical preparation quantities, but long-term safety, hepatotoxicity, nephrotoxicity, or haematological effects remain uninvestigated. No drug interaction studies exist; however, theoretical caution is warranted regarding concurrent use with anticoagulants (tannin-mediated protein binding), immunosuppressants (given immunostimulant NRAMP-1 upregulation), and hypoglycaemic agents (given moderate α-glucosidase inhibition at 630 µg/mL). Safety in pregnancy and lactation has not been studied, and use in these populations should be avoided until evidence is available.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Coleus scutellarioidesPlectranthus scutellarioidesMianaPainted NettleCommon ColeusAti-pula-pula
Frequently Asked Questions
What is Puri Puri used for in Papua New Guinea?
In the Siwai and Buin areas of Bougainville, Papua New Guinea, Puri Puri (Coleus scutellarioides) is traditionally applied to wounds as a topical preparation made from fresh or decocted leaves. Its wound-healing use is supported ethnobotanically and is consistent with the plant's documented antimicrobial activity against pathogens such as Streptococcus pyogenes and its antioxidant capacity (DPPH IC₅₀ as low as 70.06 µg/mL), though no human clinical trials have formally validated this application.
What bioactive compounds are found in Coleus scutellarioides leaves?
Coleus scutellarioides leaves contain flavonoids (including quercetin-type compounds totalling up to 8.59 mg RE/g in ethanol extract), phenolic acids, tannins, saponins, alkaloids, and anthocyanins responsible for the plant's characteristic pigmentation. The essential oil fraction includes thymol, carvacrol, eugenol, spathulenol (24.57% of volatiles), and germacrene-D (14.53%), which contribute to the plant's antimicrobial and antioxidant properties.
Are there clinical trials proving Puri Puri works?
No human clinical trials have been published for Puri Puri or Coleus scutellarioides in any therapeutic indication; all available formalised evidence derives from in vitro bioassays and animal studies. Evidence from rodent models shows immunostimulant effects via NRAMP-1 upregulation, and in vitro assays confirm antioxidant and antibacterial activity, but these findings cannot be directly translated to human efficacy without controlled clinical investigation.
Is Coleus scutellarioides safe to use?
Long-term human safety data for Coleus scutellarioides does not exist in the peer-reviewed literature, and no formal toxicology studies, maximum safe dose, or comprehensive drug interaction profiles have been established. Traditional use in Indonesia and Papua New Guinea over many decades without widely reported adverse effects suggests general tolerability at typical preparation amounts, but use during pregnancy and lactation should be avoided, and caution is advisable for individuals taking anticoagulants, immunosuppressants, or hypoglycaemic medications due to theoretical interactions.
How is Puri Puri traditionally prepared?
Traditional preparations involve using fresh or dried Coleus scutellarioides leaves as aqueous decoctions consumed orally or applied topically to affected areas such as wounds. In research contexts, ethanolic extracts are prepared by macerating approximately 3 g of dried leaves in 95–96% ethanol followed by filtration and concentration; no commercially standardised supplement capsule or tablet form currently exists, and no evidence-based human dosing protocol has been published.
What is the difference between Puri Puri leaf extract and whole leaf preparations?
Puri Puri leaf extracts, particularly those using 96% ethanol, concentrate bioactive compounds like flavonoids and phenolics to levels reaching 8.59 mg RE/g, providing higher antioxidant potency per dose compared to whole leaf preparations. Whole leaf preparations retain the full plant matrix and may offer synergistic benefits from co-occurring compounds, though with lower concentration of individual active constituents. Ethanol extracts demonstrate superior DPPH and nitric oxide radical scavenging activity (IC₅₀ 70 μM), making them preferable for antioxidant-focused applications. The choice depends on whether concentrated bioactive delivery or whole-plant synergy is the therapeutic goal.
Who should consider using Puri Puri for wound healing support?
Individuals in regions with limited access to conventional wound care, particularly in Papua New Guinea where the Siwai and Buin communities have long-standing traditional use, may benefit from Puri Puri's wound-healing properties supported by its tannin and phenolic content. Those with minor cuts, abrasions, or wounds seeking natural antimicrobial and tissue-repair support may find topical application beneficial, as the compound profile reduces oxidative burden and limits microbial colonization. However, those with severe wounds, compromised immune function, or infections requiring systemic treatment should prioritize conventional medical care over topical herbal preparations. Individuals with known allergies to Coleus species or members of the mint family (Lamiaceae) should avoid use.
How does Puri Puri's antioxidant strength compare to other herbal antioxidants?
Puri Puri leaf extracts demonstrate measurable DPPH radical scavenging and nitric oxide radical-scavenging activity with an IC₅₀ of 70 μM, placing it within the moderate-to-good range for botanical antioxidants, though specific comparative data against standardized antioxidants like vitamin C or other herbs is limited in published literature. The flavonoid content of 8.59 mg RE/g in optimized ethanol extracts suggests reasonable antioxidant potential, though direct side-by-side studies with other popular antioxidant herbs (e.g., green tea, turmeric) have not been widely published. Most evidence for Puri Puri's antioxidant benefit remains rooted in traditional use patterns and in vitro assays rather than comparative clinical trials. Further research comparing Puri Puri extracts to other botanical antioxidants would clarify its relative efficacy.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w puri-puri-coleus-scutellarioides curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
